Six insurers, one independent signal.
UNH, ELV, CI, HUM, CNC, CVS — the basket performance vs XLV tells you whether managed care is in a regime of its own, separate from pharma and biotech.
Why managed care is tracked separately
Health insurance companies are big — UnitedHealth alone has a higher market cap than most pharma giants. They're classified as healthcare on every exchange. But they trade on entirely different drivers:
- Medical-loss ratio (MLR) — what percent of premium dollars go to medical claims. Higher MLR = lower margin. The Affordable Care Act caps MLR at 85% for large group plans.
- Medicare Advantage rate notices — CMS announces MA payment rates each spring. A favorable notice can move HUM 15% in a day; an unfavorable one can take 20% off.
- Star ratings — CMS quality scores that determine MA bonus payments. Downgrades hit hard.
- Regulatory exposure — Medicaid eligibility redeterminations, ACA marketplace policy, drug-pricing rules.
None of these have anything to do with patent cliffs, Phase 3 readouts, or biotech IPO windows. Folding insurers into either the pharma or biotech gauge would dilute both.
The basket
Six names cover the major segments of US health insurance:
| Ticker | Company | Primary exposure |
|---|---|---|
| UNH | UnitedHealth Group | Diversified — insurance + Optum services arm. The bellwether. |
| ELV | Elevance Health | Blue Cross licensee in 14 states; commercial-heavy |
| CI | Cigna Group | Commercial + Express Scripts (one of the big three PBMs) |
| HUM | Humana | Medicare Advantage pure-play — most rate-notice sensitive |
| CNC | Centene | Medicaid + ACA Marketplace; redetermination-exposed |
| CVS | CVS Health | Aetna insurance + Caremark PBM + retail pharmacy |
Status thresholds
Status is computed from the equal-weighted basket's 30-day return minus XLV's 30-day return:
- Surging — outperforming XLV by more than 10% in 30 days. Either rate notice tailwind, sector rotation, or earnings beat. Typically followed by mean reversion within 60 days.
- Strong — outperforming by 3–10%. Healthy regime, no overbought signal.
- Stable — within 2 points of XLV. Tracking the sector — the default state.
- Pressured — trailing XLV by 2–8%. Often correlated with MA cycle anxiety, MLR concerns, or specific company stress (UNH cyber, CVS Aetna integration, etc.).
- Stressed — trailing by more than 8%. Real regime stress; historically correlated with MA rate-notice cycles or major regulatory events.
How to read the signal
Managed Care Watch is not a "buy" or "sell" indicator. It's a regime indicator. When the basket is Surging while pharma is in Fear, that's an unusual divergence worth understanding — typically it means rate-notice tailwind specific to insurers, not a broader healthcare sentiment shift. When all three (pharma, biotech, managed care) are Pressured or Stressed simultaneously, that's a sector-wide risk-off signal that goes beyond healthcare itself.
The most informative reads are when managed care diverges from the two main gauges. Same-direction moves usually reflect macro flows; opposite-direction moves usually reflect insurance-specific catalysts.